Scholars Central

Conference abstractPublished 10 Dec 2015

Regulatory relationship of microRNAs in Alzheimer and Huntington diseases: A cladistic approach

Authors: Prachi Srivastava, Ruchi Yadav

Amity University, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

MicroRNAs (miRNAs) are small noncoding RNA gene products about 18 to 24-nt-long. Mainly they negatively regulate protein expression of specific mRNA by either translational inhibition or mRNAs degradation. Mature miRNAs are the results of successive processing of primary transcripts (pri-miRNAs) which are facilitated by two RNase III enzymes, Drosha and Dicer with a characteristic hairpin secondary structure. Reporting of the aberrant expressions of miRNAs have been done in respect to different human diseases mainly in concern with cancer viz., lung cancer, brain cancer, chronic lymphocytic leukemia, neurodegenerative diseases etc. It is well established fact that miRNAs defines the expression patterns of the tissuespecificity. Neurodegenerative disease states the physiological nature of the cell, expression of miR-29a, miR-29b-1 and miR-9 are found significantly down regulated in AlzheimerâÂ?Â?s disease. Biopsies of tumor from ParkinsonâÂ?Â?s disease patients exposed association of miR-30b, miR-30c and miR-26a. Phylogenetic analysis of miRNA of Alzheimer and Huntington diseases gives insight into evolutionary relationship and reveals regulation of Mir-22, Mir 29a and mir-128-1 in both diseases. Mir-22 shows down-regulation in Parkinson disease and Alzheimer disease while mir-128-1 and mir-29a shows the difference in their regulation pattern. In Alzheimer disease mir-128-1 is up regulated while in Huntington disease it is down regulated. Mir-29a is up regulated in Huntington disease while in Alzheimer disease, it is down regulated. These findings illustrates the importance of miRNA research in neurodegenerative diseases with reference to novel targets identification which can give a better lead in concern to protective or prophylective approaches.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Biotechnology & Biomaterials.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Biotechnology & Biomaterials
  • SubjectBiochemistry & Biotechnology
  • SubjectMaterials Science
  • BylineArticles whose byline prints “Prachi Srivastava”
  • BylineArticles whose byline prints “Ruchi Yadav”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels